Risk-adapted procedures for HSCT from alternative donor in children with severe aplastic anaemia

Area of Science:

• Pediatric Hematology
• Transplantation Immunology
• Hematopoietic Stem Cell Transplantation

Background:

• Severe aplastic anemia (SAA) in children presents significant treatment challenges.
• Hematopoietic stem cell transplantation (HSCT) has emerged as a viable curative option.
• Advances in donor selection and conditioning regimens have improved HSCT outcomes.

Purpose of the Study:

• To review the current status and optimal strategies for HSCT in pediatric SAA.
• To highlight the importance of HLA matching and donor selection.
• To discuss conditioning regimens and stem cell sources for improved engraftment and reduced complications.

Main Methods:

• Review of recent literature on HSCT for pediatric SAA.
• Analysis of outcomes based on donor type (matched unrelated, mismatched related/unrelated).
• Evaluation of conditioning regimens (TBI vs. non-TBI) and stem cell sources (BM vs. PBSC).

Main Results:

• Outcomes for HSCT from matched unrelated donors in pediatric SAA have significantly improved.
• High-resolution HLA typing (class I and II) is crucial for donor selection.
• Non-TBI conditioning (fludarabine, CY, ATG) is effective with unmanipulated bone marrow (BM) for 9/10 or 10/10 matched donors.
• Bone marrow is preferred over peripheral blood stem cells (PBSC) in young patients due to lower cGVHD rates.
• HSCT from mismatched donors remains high-risk, with potential benefits from graft manipulation techniques like CD3/CD19 depletion.

Conclusions:

• HSCT from matched unrelated donors should be offered to pediatric SAA patients unresponsive to initial immunosuppressive therapy.
• Careful donor selection and appropriate conditioning regimens are key to successful HSCT.
• Further research into graft manipulation techniques may improve outcomes for HSCT from mismatched donors.